Healx

Accelerating treatments for rare diseases using AI-powered and patient-inspired solutions.

Rare diseases affect 400 million people worldwide, but 95% of these diseases don't have an approved treatment.

Our mission is to bring 100 rare disease treatments towards the clinic by 2025.

Healx uses AI to repurpose and combine existing drugs, significantly reducing the time, cost, and risk of drug discovery, thereby developing faster, cheaper, and safer treatments for rare diseases.

Our AI-powered product 'Healnet' leverages a comprehensive knowledge graph to transform data into actionable drug discovery insights, facilitating combination therapies, biomarker discovery, and drug repurposing.

Our therapeutic pipeline shows multiple ongoing projects across various stages, from in silico discovery to clinical trials.

Our seasoned leadership and collaborative board bring decades of drug discovery, scientific expertise, and strategic partnerships, driving our innovation in healthcare.